Increases in plasmatrans-EETs and blood pressure reduction in spontaneously hypertensive rats
- 1 June 2011
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 300 (6), H1990-H1996
- https://doi.org/10.1152/ajpheart.01267.2010
Abstract
Epoxyeicosatrienoic acids (EETs) are vasodilator, natriuretic, and antiinflammatory lipid mediators. Both cis- and trans-EETs are stored in phospholipids and in red blood cells (RBCs) in the circulation; the maximal velocity ( Vmax) of trans-EET hydrolysis by soluble epoxide hydrolase (sEH) is threefold that of cis-EETs. Because RBCs of the spontaneously hypertensive rat (SHR) exhibit increased sEH activity, a deficiency of trans-EETs in the SHR was hypothesized to increase blood pressure (BP). This prediction was fulfilled, since sEH inhibition with cis-4-[4-(3-adamantan-1-ylureido)cyclohexyloxy]benzoic acid (AUCB; 2 mg·kg−1·day−1for 7 days) in the SHR reduced mean BP from 176 ± 8 to 153 ± 5 mmHg ( P < 0.05), whereas BP in the control Wistar-Kyoto rat (WKY) was unaffected. Plasma levels of EETs in the SHR were lower than in the age-matched control WKY (16.4 ± 1.6 vs. 26.1 ± 1.8 ng/ml; P < 0.05). The decrease in BP in the SHR treated with AUCB was associated with an increase in plasma EETs, which was mostly accounted for by increasing trans-EET from 4.1 ± 0.2 to 7.9 ± 1.5 ng/ml ( P < 0.05). Consistent with the effect of increased plasma trans-EETs and reduced BP in the SHR, the 14,15- trans-EET was more potent (ED5010−10M; maximum dilation 59 ± 15 μm) than the cis-isomer (ED5010−9M; maximum dilation 30 ± 11 μm) in relaxing rat preconstricted arcuate arteries. The 11,12-EET cis- and trans-isomers were equipotent dilators as were the 8,9-EET isomers. In summary, inhibition of sEH resulted in a twofold increase in plasma trans-EETs and reduced mean BP in the SHR. The greater vasodilator potency of trans- vs. cis-EETs may contribute to the antihypertensive effects of sEH inhibitors.Keywords
This publication has 58 references indexed in Scilit:
- Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension‐induced renal injury in miceThe FASEB Journal, 2010
- Epoxyeicosatrienoic acids and endothelium-dependent responsesPflügers Archiv - European Journal of Physiology, 2010
- Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertensionAmerican Journal of Physiology-Renal Physiology, 2009
- Fatty Acid Hydroperoxides Support Cytochrome P450 2S1-Mediated Bioactivation of Benzo[a]pyrene-7,8-dihydrodiolMolecular Pharmacology, 2009
- Bilirubin and glutathione have complementary antioxidant and cytoprotective rolesProceedings of the National Academy of Sciences of the United States of America, 2009
- Hydrolysis ofcis- andtrans-Epoxyeicosatrienoic Acids by Rat Red Blood CellsThe Journal of pharmacology and experimental therapeutics, 2008
- Stimulation of rat erythrocyte P2X7 receptor induces the release of epoxyeicosatrienoic acidsBritish Journal of Pharmacology, 2007
- Orally Bioavailable Potent Soluble Epoxide Hydrolase InhibitorsJournal of Medicinal Chemistry, 2007
- Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivoProceedings of the National Academy of Sciences of the United States of America, 2007
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959